Cidália Pina Vaz
Cidália Pina Vaz
OrcidAuthenticus

Research Group: MicroMed – Medical Microbiology
Thematic Line:  TL2 – Clinical & Translational Research addresses
Hub: Faculty of Medicine of the University of Porto
Research Areas: Microbiology, Infectious Diseases, Mycology, Pharmacology and Pharmacy, Dermatology, Biochemical Research Methods

updated on 19/03/2018

Cidália Pina Vaz is an integrated researcher of the MicroMed research group of CINTESIS.

She is a Medical Specialist in Clinical Pathology, integrating the clinical staff of the Hospital Centre of São João since 1994. She is also an Associate Professor at FMUP, at the Microbiology Laboratory, since 2000.

Cidália Pina Vaz is the CEO of FASTinov, a U.Porto-born company that received 2.6 million euros from the European Commission to launch a clinical diagnostic kit that allows the determination of the susceptibility of bacteria to antibiotics from blood cultures in 60 minutes. The scientist was also responsible for several scientific projects, namely funded by the Portuguese Foundation for Science and Technology and by the industry.

She has already authored around 100 scientific articles and accumulates in her curriculum several awards, attributed by entities such as the Laboratories LabMed and Pfizer.

Currently, she is also a member of the Board of Directors of the Portuguese Society of Infectious Diseases and Clinical Microbiology (SPDIMC in Portuguese).

TITLE: Antifungal activity of Thymus oils and their major compounds  Full Text
AUTHORS: Pina Vaz, C ; Rodrigues, AG ; Pinto, E ; Costa de Oliveira, S ; Tavares, CSatgueiro, L ; Cavaleiro, C ;Goncalves, MJ ; Martinez de Oliveira, J ;
SOURCE: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, VOLUME: 18, ISSUE: 1,PUBLISHED: 2004

TITLE: Antifungal activity of the essential oil of Thymus pulegioides on Candida, Aspergillus and dermatophyte species
AUTHORS: Eugenia Pinto ; Cidalia Pina Vaz ; Ligia Salgueiro ; Maria Jose Goncalves ; Sofia Costa de Oliveira ; Carlos Cavaleiro ; Ana Palmeira ; Acacio Rodrigues ; Jose Martinez de Oliveira ;
SOURCE: JOURNAL OF MEDICAL MICROBIOLOGY, VOLUME: 55, ISSUE: 10, PUBLISHED: 2006

TITLE: Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals
AUTHORS: Pina Vaz, C ; Sansonetty, F ; Rodrigues, AG ; Costa Oliveira, S ; Tavares, C; Martinez de Oliveira, J;
SOURCE: CLINICAL MICROBIOLOGY AND INFECTION, VOLUME: 7, ISSUE: 11, PUBLISHED: 2001

TITLE: New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes
AUTHORS: Sampaio, P ; Gusmao, L ; Correia, AAlves, CRodrigues, AG ; Pina Vaz, C ; Amorim, A ; Pais, C ;
SOURCE: JOURNAL OF CLINICAL MICROBIOLOGY, VOLUME: 43, ISSUE: 8, PUBLISHED: 2005

TITLE: Prevalence, Distribution, and Antifungal Susceptibility Profiles of Candida parapsilosis, C-orthopsilosis, and C-metapsilosis in a Tertiary Care Hospital
AUTHORS: Ana P Silva ; Isabel M Miranda ; Carmen Lisboa ; Cidalia Pina Vaz ; Acacio G Rodrigues ;
SOURCE: JOURNAL OF CLINICAL MICROBIOLOGY, VOLUME: 47, ISSUE: 8, PUBLISHED: 2009

View full list